Vacant Lot Greening and Violence-Related Outcomes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01336374|
Recruitment Status : Completed
First Posted : April 15, 2011
Last Update Posted : December 5, 2011
|Condition or disease|
|Violence Prevention Built Environment|
|Study Type :||Observational|
|Actual Enrollment :||29 participants|
|Observational Model:||Ecologic or Community|
|Official Title:||A Pilot Randomized Controlled Trial of Vacant Lot Greening and Violence-related Outcomes|
|Study Start Date :||April 2011|
|Actual Primary Completion Date :||August 2011|
|Actual Study Completion Date :||September 2011|
Greened Vacant Lot
A cluster of vacant lots is greened. People living around this area make up this cohort.
The control site is a cluster of vacant lots that will not be greened. The people living around these lots make up the control group.
- Perceptions of safety and violence [ Time Frame: measured twice - once during first month of study and once during 4th or 5th month. ]We will be performing qualitative interviews to assess perceptions of safety and violence. We will compare these perceptions over time between two groups.
- Heart Rate [ Time Frame: measured twice - once during first month of study and once during 4th or 5th month of study ]Participants wear a heart rate monitor during a walk around their neighborhood.
- Violent crime statistics [ Time Frame: Measured 6 months before intervention and 6 months after intervention ]We will obtain crime statistics, including homicide, robbery, rape, and assault in the area around each cluster of vacant lots.
- Safe/Unsafe items in the environment [ Time Frame: measured twice - once during the first month of the study and once during the 4th or 5th month. ]During a walk around the neighborhood, participants will point out items in the environment which they feel are safe or unsafe.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01336374
|United States, Pennsylvania|
|University of Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19104|
|Principal Investigator:||Eugenia C Garvin, MD||University of Pennsylvania|